MSD Vidaza

Non-malignant hematology topics. For Leukemias and lymphomas please use the Oncology (Cancer) Forums.

Moderators: Radiodiagnosis Team, Primary Care Team, Cardiology Team

Forum rules
YOUR POST WILL REQUIRE APPROVAL - READ: Doctors Lounge Forum Rules and Regulations
• Use a precise title for your question otherwise it will NOT be approved.
• Do not post the same question more than once & maintain related posts in original thread.
• Do not use your real name or identifiable information - You can't edit/delete your post.
Posts: 1
Joined: Wed Nov 30, 2005 8:13 am
Location: BILBAO

MSD Vidaza

Postby aitzi » Wed Nov 30, 2005 8:18 am

My father has been diagnosed witn Mielodispalsia (mielodisplastic sindrome or MSD), we heard vidaza is a medicamente it`s having success in some patients, so we wants to try it, the problem is we live in spain and it,s not available there, so could we just buy it in USA and then be treated in spain with it? where can we get vidaza?

User avatar
Dr. Safaa Mahmoud
Medical Doctor
Posts: 1434
Joined: Sat Jan 04, 2003 7:53 am

Postby Dr. Safaa Mahmoud » Wed Jul 26, 2006 2:02 pm

Dear aitzi,

MDSs is more commonly seen in men above 65years old. Various cytopenias, including anemia, may persist for months to years before the diagnosis is settled.

Dyspoiesis in normocellular or hypercellular bone marrow is the main feature of this disease and include:
Dyserythropoiesis: ineffective erythropoiesis results in anemia and reticulocytopenia; anisocytosis and poikilocytosis
Dysgranulocytopoiesis: Neutropenia; decreased or abnormal neutrophils.
Dysmegakaryocytopoiesis Thrombocytopenia; large platelets with abnormal contents.

Management of MDSs is usually conservative till leukemic transformation.
Supportive care includes packed red blood cell transfusion, platelet transfusion, treatment of infection etc.

Androgens, pyridoxine, folate, and danazol
High doses of erythropoietin (5000 to 10,000 U/day) is helpful in 10% to 20% of patients. Other growth factors

Cytotoxic agents like Low dose cytosar therapy or topotecan showed activity in the treatment of this disease.

Bone marrow transplantation (BMT) should be considered in patients younger than 45 years of age who have an HLA-compatible sibling.

New drugs like Vidaza have shown to be effective in decreasing the transfusion needs and providing better quality of life, however no long term control of the disease could be demonstrated till now.

To read more about Vidaza you can visit our web page: ... _approval/

Best regards,
This answer does not substitute for direct medical consultation.

Dr. Safaa Mahmoud.
MB BCh, MSc Internal Medicine. MD Medical Oncology.
PhD Experimental Medicine and Biochemical Science.

Return to “Hematology Topics”

Who is online

Users browsing this forum: No registered users and 2 guests

advertisement.gif (61x7 -- 0 bytes)

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2016 Doctors Lounge. All rights reserved.